tiprankstipranks
Trending News
More News >
Cautious Outlook on Editas Medicine: Hold Rating Amidst Preclinical Progress and Financial Considerations
PremiumRatingsCautious Outlook on Editas Medicine: Hold Rating Amidst Preclinical Progress and Financial Considerations
1M ago
Promising Preclinical Data and Market Opportunities Drive Buy Rating for Editas Medicine
Premium
Ratings
Promising Preclinical Data and Market Opportunities Drive Buy Rating for Editas Medicine
1M ago
Editas Medicine Reports Q1 2025 Progress and Financials
Premium
Company Announcements
Editas Medicine Reports Q1 2025 Progress and Financials
2M ago
Editas Medicine price target lowered to $4 from $8 at Baird
PremiumThe FlyEditas Medicine price target lowered to $4 from $8 at Baird
2M ago
Editas Medicine: Hold Rating Amid Legal Uncertainty and Financial Concerns
Premium
Ratings
Editas Medicine: Hold Rating Amid Legal Uncertainty and Financial Concerns
2M ago
Buy Rating for Editas Medicine: Promising Advancements in In Vivo Gene Editing
Premium
Ratings
Buy Rating for Editas Medicine: Promising Advancements in In Vivo Gene Editing
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Cognex, Editas, Akebia, Tvardi, Chipotle: Trending by Analysts
Premium
Weekend Updates
Cognex, Editas, Akebia, Tvardi, Chipotle: Trending by Analysts
2M ago
Editas Medicine initiated with a Buy at H.C. Wainwright
Premium
The Fly
Editas Medicine initiated with a Buy at H.C. Wainwright
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100